Robert B. Huizinga
Impact in
- Rheumatology top 1%
- Systemic Lupus Erythematosus Research
- Rheumatoid Arthritis Research and Therapies
- Transplantation top 5%
- Renal Transplantation Outcomes and Treatments
Papers in
- Rheumatology 13
- Systemic Lupus Erythematosus Research 13
-
- Renal Transplantation Outcomes and Treatments 8
- Co-authors
- Laura Lisk (4 shared papers)Neil Solomons (7 shared papers)Dawn J. Caster (4 shared papers)Samir V. Parikh (5 shared papers)Simrat Randhawa (4 shared papers)Onno YK Teng (3 shared papers)Keisha L. Gibson (4 shared papers)Ellen M. Ginzler (3 shared papers)
- Journals
- Nephrology Dialysis Transplantation (3 papers)The Journal of Clinical Pharmacology (3 papers)The Lancet (2 papers)Arthritis & Rheumatology (2 papers)American Journal of Kidney Diseases (1 paper)
- Partner nations
- United StatesCanadaNetherlands
In The Last Decade
Robert B. Huizinga
24 papers receiving 1.1k citations
Robert B. Huizinga's Hit Papers
Peers
Comparison fields: 5 of 55
- Rheumatology 768
- Transplantation 88
- Nephrology 66
- Immunology 79
- Toxicology 16
Countries citing papers authored by Robert B. Huizinga
This map shows the geographic impact of Robert B. Huizinga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert B. Huizinga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert B. Huizinga more than expected).
Fields of papers citing papers by Robert B. Huizinga
This network shows the impact of papers produced by Robert B. Huizinga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert B. Huizinga. The network helps show where Robert B. Huizinga may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert B. Huizinga, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial Hit paper breakdown → | 2021 | 417 |
| 2 | 2018 | 231 | |
| 3 | 2023 | 72 | |
| 4 | 2008 | 68 | |
| 5 | 2011 | 68 | |
| 6 | 2006 | 44 | |
| 7 | 2022 | 42 | |
| 8 | 2022 | 34 | |
| 9 | 2020 | 27 | |
| 10 | 2021 | 21 | |
| 11 | 2013 | 18 | |
| 12 | 2013 | 14 | |
| 13 | 2008 | 13 | |
| 14 | 2013 | 12 | |
| 15 | 2013 | 11 | |
| 16 | 2020 | 5 | |
| 17 | 2017 | 3 | |
| 18 | 2020 | 3 | |
| 19 | 2024 | 2 | |
| 20 | 2025 | 2 |
About Robert B. Huizinga
Robert B. Huizinga is a scholar working on Rheumatology, Transplantation, Immunology, Rehabilitation and Dermatology, having authored 28 papers that have together received 1.1k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (13 papers), Renal Transplantation Outcomes and Treatments (8 papers), Psoriasis: Treatment and Pathogenesis (3 papers), Signaling Pathways in Disease (2 papers), Pharmacogenetics and Drug Metabolism (1 paper), Bacterial biofilms and quorum sensing (1 paper), Renal Diseases and Glomerulopathies (1 paper) and Wound Healing and Treatments (1 paper). The work is most often cited by research in Rheumatology (768 citations), Transplantation (88 citations), Nephrology (66 citations), Immunology (79 citations) and Toxicology (16 citations). Robert B. Huizinga has collaborated with scholars based in United States, Canada and Netherlands. Frequent co-authors include Laura Lisk, Neil Solomons, Dawn J. Caster, Samir V. Parikh, Simrat Randhawa, Onno YK Teng, Keisha L. Gibson, Ellen M. Ginzler, Cristina Arriens and Brad H. Rovin. Their work appears in journals such as Nephrology Dialysis Transplantation, The Journal of Clinical Pharmacology, The Lancet, Arthritis & Rheumatology and American Journal of Kidney Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.